Patent: 10,150,800
✉ Email this page to a colleague
Summary for Patent: 10,150,800
| Title: | EGFR-binding modular recognition domains |
| Abstract: | EGFR-binding modular recognition domains (MRDs) and complexes containing such MRDs linked to antibodies are described. The use of such MRDs and complexes are also described. |
| Inventor(s): | Roschke; Viktor (Bethesda, MD), Lafleur; David (Washington, DC), Hilbert; David M. (Bethesda, MD), Kiener; Peter (Potomac, MD) |
| Assignee: | Zyngenia, Inc. (Washington, DC) |
| Application Number: | 14/776,816 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,150,800
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 02/12/2004 | See Plans and Pricing | 2039-02-26 |
| Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 03/28/2007 | See Plans and Pricing | 2039-02-26 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
